Key players in the injectable
drug delivery market include Becton, Dickinson and Company (U.
Injectable Drug Delivery Market, 2020 - Becton, Dickinson and Company, Baxter, Gerresheimer, Pfizer,, Schott, Sandoz, Teva, and Eli Lilly Dominate the $574 Billion Industry
Some of the drugs that are commonly administered by injectable
drug delivery include analgesics, antibiotics, immunosuppressive agents, antihypertensive agents, vasodilators, chemotherapeutic agents and antiarrhythmic drugs.
Two-thirds had ever used oral contraceptives, and roughly one in 10 women had used the injectable
Access to over 150 injectable
drug delivery actual deal records
Explores clinical applications of injectable
biomaterials, including drug delivery, tissue engineering, orthopaedic applications and injectable
materials for gene delivery systems
Commenting on the report, an analyst from TechNavio's Healthcare team said, Although the Americas and the EMEA region are the main revenue generators in the Global Facial Injectable
market, the majority of the global vendors are focusing on the APAC region.
The report provides a detailed understanding and analysis of how and why companies enter injectable
drug delivery partnering deals.
Drug Delivery Market By Formulations[Liposomes, Microspheres, & Nanoparticles], Devices[Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics[Diabetes & Oncology] - Forecasts to 2017
Nasdaq: ARTE), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable
products for men and women, today announced its first shipment of ArteFill([R]) to trained physicians.
The said report is a study of the UK injectable
market in terms of major therapeutic areas.
Drug Delivery Market Dynamics The Injectable
Drug Ecosystem Injectable
Drug Device Selection Criteria Stability and Material Selection Issues Injectable
Drug Delivery - Device Segments Autoinjectors Needle-free Injectors Pen Injectors Prefilled Syringes Safety Syringes Injectable
Drug Delivery - Therapeutic Segment Analysis & Forecasts Injectable
Drug Therapeutics - Market Factors Regulatory Factors and Issues Company Profiles
Alkermes currently has two commercial products: RISPERDAL([R]) CONSTA([R])[(risperidone) long-acting injection], the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson & Johnson; and VIVITROL([R]) (naltrexone for extended-release injectable
suspension) the first and only once-monthly injectable
medication approved for the treatment of alcohol dependence and marketed in the U.